DP VII ASSOCIATES LP
Insider CIK 1372932 · AKAO 10% owner · TBRA 10% owner · CADX 10% owner · EVOK 10% owner · OBLN 10% owner · ESPR 10% owner · TNDM 10% owner · CLVS 10% owner · NEOT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 47,613 | $28.35 | $1.35M | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 20,583 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 14,271 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 11,083 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion | 2016-10-12 | 2016-10-14 | 49,570 | — | $0 | 49,570 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-05-26 | 2016-05-27 | 5,880 | $4.70 | $27.6K | 10,328 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-27 | 2016-04-27 | 61 | $5.02 | $306 | 16,208 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-25 | 2016-04-27 | 21 | $5.20 | $109 | 16,269 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-20 | 2016-04-21 | 76 | $5.29 | $402 | 16,290 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-19 | 2016-04-21 | 632 | $5.36 | $3.4K | 16,366 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-11 | 2016-04-13 | 75 | $5.22 | $392 | 16,998 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-08 | 2016-04-08 | 251 | $5.35 | $1.3K | 17,073 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-07 | 2016-04-08 | 475 | $5.26 | $2.5K | 17,324 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-06 | 2016-04-08 | 148 | $5.22 | $773 | 17,799 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-08-18 | 2015-08-20 | 202 | $7.02 | $1.4K | 17,947 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-16 | 2015-04-16 | 554 | $7.07 | $3.9K | 18,149 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-15 | 2015-04-16 | 135 | $7.58 | $1.0K | 18,703 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-14 | 2015-04-16 | 168 | $7.78 | $1.3K | 18,838 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 2,827 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 12,578 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 104,247 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 36,913 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 102,282 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 1,570 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 1,570 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 2,827 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 102,282 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 36,913 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 104,247 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 12,578 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-26 | 46,309 | — | $0 | 46,309 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 958 | $14.00 | $13.4K | 46,921 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 2,827 | $8.54 | $24.1K | 49,748 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 1,725 | $14.00 | $24.1K | 48,023 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 1,570 | $8.54 | $13.4K | 47,879 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 958 | $14.00 | $13.4K | 46,923 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-12-10 | 46,311 | — | $0 | 46,311 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 1,725 | $14.00 | $24.1K | 48,025 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 2,827 | $8.54 | $24.1K | 49,750 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 1,570 | $8.54 | $13.4K | 47,881 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 50,743 | $14.00 | $710.4K | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 10,661 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 15,799 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 7,430 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion | 2014-03-17 | 2014-03-17 | 33,890 | — | $0 | 33,890 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-14 | 23,317 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-14 | 13,058 | $14.00 | $182.8K | 50,743 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-14 | 23,317 | $7.84 | $182.8K | 63,801 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 38,941 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 10,068 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 6,008 | — | $0 | 6,008 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 9,378 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 6,071 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-19 | 54,390 | — | $0 | 54,390 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion deriv | 2013-09-30 | 2013-09-30 | 19,006 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion | 2013-09-30 | 2013-09-30 | 19,006 | — | $0 | 19,006 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 8,346 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 1,193 | — | $0 | 1,193 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-02 | 30,462 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-02 | 4,791 | $14.00 | $67.1K | 35,253 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-02 | 30,462 | — | $0 | 30,462 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-04 | 2013-06-05 | 2,779 | $64.58 | $179.5K | 44,034 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 893 | $5.49 | $4.9K | 40,484 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 92 | $5.22 | $480 | 41,377 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 134 | $5.19 | $695 | 41,469 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 135 | $5.16 | $697 | 41,603 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 163 | $5.28 | $861 | 41,738 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 85 | $5.36 | $456 | 41,901 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 131 | $5.40 | $707 | 41,986 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 107 | $5.38 | $576 | 42,117 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 70 | $5.34 | $374 | 42,224 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 88 | $5.32 | $468 | 42,294 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 215 | $5.22 | $1.1K | 42,382 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-06 | 2013-03-06 | 1,651 | $24.51 | $40.5K | 46,813 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 65 | $5.06 | $329 | 42,597 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-05 | 2013-03-06 | 2,132 | $24.69 | $52.6K | 48,464 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-05 | 2013-03-07 | 69 | $5.01 | $346 | 42,662 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-04 | 2013-03-05 | 88 | $5.01 | $441 | 42,731 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-04 | 2013-03-06 | 417 | $24.44 | $10.2K | 50,596 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-01 | 2013-03-05 | 130 | $5.01 | $651 | 42,819 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-20 | 2013-02-22 | 34 | $5.01 | $170 | 42,949 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-19 | 2013-02-20 | 171 | $5.02 | $858 | 42,983 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-15 | 2013-02-20 | 51 | $5.00 | $255 | 43,154 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-14 | 2013-02-15 | 51 | $5.01 | $256 | 43,205 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-13 | 2013-02-15 | 98 | $5.00 | $490 | 43,256 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-01 | 2013-02-05 | 164 | $4.85 | $795 | 43,354 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-31 | 2013-02-01 | 314 | $4.71 | $1.5K | 43,518 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-30 | 2013-02-01 | 188 | $5.00 | $940 | 43,832 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 260 | $5.27 | $1.4K | 44,020 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 282 | $5.40 | $1.5K | 44,280 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-25 | 2013-01-28 | 234 | $5.38 | $1.3K | 44,562 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-24 | 2013-01-28 | 616 | $5.45 | $3.4K | 44,796 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-23 | 2013-01-24 | 430 | $5.11 | $2.2K | 45,412 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-22 | 2013-01-24 | 254 | $5.02 | $1.3K | 45,842 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-18 | 2013-01-22 | 324 | $5.19 | $1.7K | 46,096 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-17 | 2013-01-22 | 214 | $5.35 | $1.1K | 46,420 | SEC↗ |